RIP1

CAT # Magaca Alaabta Sharaxaada
CPD3508 GSK547 GSK547 waa mid aad u doora oo awood leh ka hortagga RIP1 kinase kaas oo bartilmaameedsada RIP1 gudaha vivo
CPDD1123 GSK2982772 GSK2982772 waa soo-dhoweeye awood leh oo la xushay Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate for the Treatment of Inflammatory Diseases.
;

Nala Soo Xidhiidh

Weydiin

Wararkii Ugu Danbeeyay

  • 7-da Isbeddel ee ugu Sarreysa ee Cilmi-baarista Dawooyinka 2018

    7-da Isbeddel ee ugu Sarreysa Cilmi-baarista Dawooyinka Waxaan...

    Iyadoo lagu jiro cadaadis sii kordhaya si loogu tartamo jawi dhaqaale iyo teknoloji oo adag, shirkadaha dawooyinka iyo bayoolojiga waa inay si joogto ah u cusbooneysiiyaan barnaamijyadooda R&D si ay horay ugu sii socdaan ...

  • ARS-1620: Horjooge cusub oo rajo leh oo loogu talagalay kansarka-KRAS-mutant

    ARS-1620: Horjooge cusub oo rajo leh oo loogu talagalay K...

    Sida laga soo xigtay cilmi-baaris lagu daabacay Cell, cilmi-baarayaashu waxay sameeyeen xannibaado gaar ah oo loogu talagalay KRASG12C oo loo yaqaan ARS-1602 taas oo keentay dib u noqoshada buro ee jiirarka. "Daraasaddani waxay ku siinaysaa caddayn vivo ah in KRAS mutant uu noqon karo ...

  • AstraZeneca waxay heshaa kor u qaadida sharciyeynta ee daawooyinka kansarka

    AstraZeneca waxay heshay kor u qaadida sharciyeynta ee...

    AstraZeneca waxay heshay labanlaab kor u qaadis ah faylalka Oncology Talaadadii, ka dib markii sharciyeeyayaasha Mareykanka iyo Yurub ay aqbaleen soo gudbinta sharciyeynta dawooyinkeeda, tallaabada ugu horreysa ee lagu guuleysto oggolaanshaha daawooyinkan. ...

WhatsApp Online chat!